Atomo Diagnostics secures $6M investment to scale up activities related to its rapid diagnostics test platform, AtomoRapid™

The Global Health Investment (GHIF) has announced it has invested $6 million into Atomo Diagnostics (Atomo) to support scale-up of production operations and expansion of commercial activities related to the multi award winning AtomoRapid rapid diagnostic test (RDT) platform.  The investment will also be used by Atomo to commercialise a self-test HIV solution for HIV on […]


World Malaria Day – 25th April

Did you know that the 25th April is World Malaria Day? Over 15 countries are still at potential risk from malaria, and last year saw 200 million cases of the mosquito bourne disease which resulted in 500,000 deaths. BBI is commited to providing biological raw materials for use in the detection and early diagnosis of […]

Purity check close up

BBI Solutions launches a new recombinant human antigen; Galectin-3

We are pleased to announced the launch of a new antigen: recombinant Galectin-3 (Gal-3) to BBI’s portfolio.  A multi-function marker which aids with the assessment and diagnosis of chronic heart failure as well as various cancer types. Galectin-3 belongs to the lectin family and is a carbohydrate binding antigen. It is predominantly expressed in the […]